CORRECTION article

Front. Psychiatry, 23 December 2024

Sec. Psychopharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fpsyt.2024.1523364

Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice

  • 1. Stanford University, Center for Biomedical Ethics, Stanford, CA, United States

  • 2. Department of Medical Ethics & Health Policy, University of Pennsylvania, Philadelphia, PA, United States

  • 3. Department of Psychiatry, University of California, San Francisco, San Francisco, CA, United States

  • 4. Sage Integrative Health, Berkeley, CA, United States

  • 5. COMPASS Pathways, London, United Kingdom

Article metrics

View details

805

Views

260

Downloads

In the published article, there were errors in Table 2. The authors wish to correct the errors and clarify data presented in Table 2, pertaining to the prevalence of mental illness in several populations.

Table 2

Disabling conditionPrevalence within disability communitiesSource
MS



ALS
Mild/Moderate Cerebral Palsya


Spinal cord injury


Traumatic brain injury





Deafnessb




Blindnessc
MDD - 46%
Anxiety - 16.5%
Bipolar - 2.4%
Schizophrenia -.2%
MDD - 17%
Anxiety Disorders - 19.5%
Mood Disorders - 19.5%
Schizophrenia - 2.8%
MDD - 20-30%
Anxiety - 13.2-40%
PTSD - 7.1–26.6%
MDD - 24.5%
Anxiety - 24.5%
Bipolar - ~1.6%
Schizophrenia - 4.0%
PTSD - 16.5%
Substance Use Disorder - 11.5%
Anxiety Disorders – 18.7%
Bipolar – 3.7%
Impulse control disorders – 15.8%
Substance Use Disorders – 27.8%
ADHD – 11.2%
MDD - 18.2%
Anxiety Disorders - 14.3%
Schizophrenia - 1.4%
Alcohol Misuse - 3.3%
Psychoactive Substance Misuse - 12.9%
Anorexia or Bulimia -.5%
Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T, 2009 (33)


Zucchi E, Ticozzi N, Mandrioli J, 2019 (34)
Whitney DG, Warschausky SA, Ng S, Hurvitz EA, Kamdar NS, Peterson MD, 2019 (35)a

Post M, van Leeuwen, C, 2012 (36)


Rogers JM, Read CA, 2007 (37)





Diaz DR, Landsberger SA, Povlinski J, Sheward J, Sculley C, 2013 (38)b



Court H, McLean G, Guthrie B, Mercer SW, Smith DJ, 2014 (39)c

Disability community prevalence of mental disorders.

a

Statistics in this table reflect the statistics for men with CP in this article.

b

This article is focused on a population in outpatient psychiatric care.

c

This article is focused on patients 65 and older in the UK.

The authors thank Jacob Kramer, an MSW student at Rhode Island College for helping bring these errors to our attention, particularly with regard to the D/deaf community.

Under “Mild/Moderate Cerebral Palsy”, the data in column 2 refer to men only. A footnote has been added to clarify this.

Under “Spinal cord injury”, the data in column 2 were reported as 7.1–26.6% and 13.2-40% for Anxiety and PTSD, respectively. The correct values are 13.2–40% and 7.1–26.6%. The table has been updated to reflect this.

Under “Deafness”, the data for Substance Use Disorder in column 2 reflect a population in outpatient psychiatric care. A footnote has been added to clarify this.

Also under “Deafness”, the data in column 2 were reported as 30.1%, 14.2%, 5.2%, 48.4% and 4.9% for Anxiety, Bipolar, Impulse control disorders, Substance Use Disorders and ADHD, respectively. The correct values are 18.7%, 3.7%, 15.8%, 27.8% and 11.2%. The table has been updated to reflect this.

Under “Blindness”, the data in column 2 refer to patients older than 65. A footnote has been added to clarify this.

The corrected Table 2 and its caption appear below.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

physical disability, sensory disability, psychedelic therapies, ethics, structural ableism in healthcare, justice, inclusion in clinical research

Citation

Mintz KT, Gammer B, Khan AJ, Shaub G, Levine S and Sisti D (2024) Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice. Front. Psychiatry 15:1523364. doi: 10.3389/fpsyt.2024.1523364

Received

05 November 2024

Accepted

22 November 2024

Published

23 December 2024

Volume

15 - 2024

Edited and reviewed by

Marijn Lijffijt, IonTX, Inc, United States

Updates

Copyright

*Correspondence: Kevin T. Mintz,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics